Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment-naïve patients.
Murata T, Kondo M, Inoue M, Nakao S, Osaka R, Shiragami C, Sogawa K, Mochizuki A, Shiraga R, Ohashi Y, Kaneko T, Chandrasekhar C, Tsujikawa A, Kamei M. Murata T, et al. Among authors: ohashi y. Sci Rep. 2021 Jan 12;11(1):551. doi: 10.1038/s41598-020-79051-1. Sci Rep. 2021. PMID: 33436683 Free PMC article. Clinical Trial.
Author Correction: The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment‑naïve patients.
Murata T, Kondo M, Inoue M, Nakao S, Osaka R, Shiragami C, Sogawa K, Mochizuki A, Shiraga R, Ohashi Y, Kaneko T, Chandrasekhar C, Tsujikawa A, Kamei M. Murata T, et al. Among authors: ohashi y. Sci Rep. 2021 Jul 7;11(1):14400. doi: 10.1038/s41598-021-93187-8. Sci Rep. 2021. PMID: 34234192 Free PMC article. No abstract available.
Impact on visual acuity and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY).
Sakamoto T, Shimura M, Kitano S, Ohji M, Ogura Y, Yamashita H, Suzaki M, Mori K, Ohashi Y, Yap PS, Kaneko T, Ishibashi T; MERCURY Study Group. Sakamoto T, et al. Among authors: ohashi y. Graefes Arch Clin Exp Ophthalmol. 2022 Feb;260(2):477-487. doi: 10.1007/s00417-021-05308-8. Epub 2021 Sep 3. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 34477927 Free PMC article.
Design and baseline characteristics of the Xarelto Post-Authorization Safety & Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS).
Ogawa S, Minematsu K, Ikeda T, Kitazono T, Nakagawara J, Miyamoto S, Murakawa Y, Ohashi Y, Takeichi M, Okayama Y, Yamanaka S, Inuyama L. Ogawa S, et al. Among authors: ohashi y. J Arrhythm. 2018 Feb 7;34(2):167-175. doi: 10.1002/joa3.12034. eCollection 2018 Apr. J Arrhythm. 2018. PMID: 29657592 Free PMC article.
Factors associated with discrepancies in disease activity as assessed by SDAI and RAPID3 in patients with rheumatoid arthritis: Data from a multicenter observational study (T-FLAG).
Suzuki M, Asai S, Ohashi Y, Sobue Y, Ishikawa H, Takahashi N, Terabe K, Sato R, Kosugiyama H, Hasegawa J, Ohno Y, Sugiura T, Imagama S. Suzuki M, et al. Among authors: ohashi y. Mod Rheumatol. 2024 May 10:roae040. doi: 10.1093/mr/roae040. Online ahead of print. Mod Rheumatol. 2024. PMID: 38727542
Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study).
Hatori M, Tsuji D, Suzuki K, Yokokawa T, Kawakami K, Moriyama R, Osada-Tsuchiya M, Otake A, Nakao M, Yano T, Arakawa Y, Matsuo K, Ohashi Y, Sakata Y, Kogure Y, Tamaki S, Wada A, Taki Y, Sasahira N, Ishii H, Yamaguchi M, Itoh K. Hatori M, et al. Among authors: ohashi y. Cancer. 2024 Apr 29. doi: 10.1002/cncr.35343. Online ahead of print. Cancer. 2024. PMID: 38682652
2,167 results